株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

欧州の血管アクセスデバイス・付属品の製品ポートフォリオ

European Product Portfolio for Vascular Access Devices and Accessories 2017 - MedFolio

発行 iData Research Inc. 商品コード 392563
出版日 ページ情報 英文 216 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=109.60円で換算しております。

※ Single Userライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。
認証されたPC上のみでの閲覧となっております。

Back to Top
欧州の血管アクセスデバイス・付属品の製品ポートフォリオ European Product Portfolio for Vascular Access Devices and Accessories 2017 - MedFolio
出版日: 2016年11月01日 ページ情報: 英文 216 Pages
概要

当レポートでは、欧州諸国で現在上市/開発されている、血管アクセスデバイスおよび付属品の製品ポートフォリオについて分析し、疾患・製品の概要や、各国市場の背景構造、現在の患者人口、上市済み製品のポートフォリオ、開発中 (治験中) の製品のパイプライン評価、主要企業の製品情報などについて調査しております。

エグゼクティブ・サマリー

欧州の血管アクセスデバイス・付属品市場:概要

競争分析

企業の傾向

企業の発展

処置件数

分析対象市場

主要分析の更新状況

過去のバージョン

分析手法

  • 分析範囲
  • IDATAの9段階の分析方法

疾患の概要

  • 人体の基本構造
    • 人体の血管系
  • 血管の病態生理と疾患
    • がん
    • 末期腎疾患
    • 糖尿病

製品評価

  • 製品ポートフォリオ
    • 埋め込み型ポートデバイス
    • ポート針
    • 中心静脈カテーテル (CVC)
    • 末梢穿刺中心静脈カテーテル (PICC)
    • 末梢静脈カテーテル (PIVC)
    • 透析カテーテル
    • 超音波血管アクセスデバイス
    • カテーテル固定器具
    • シリンジ (注射器)・針
  • 規制上の問題とリコール:2012年1月~2015年11月
  • 治験
    • 埋め込み型ポートデバイス
    • 中心静脈カテーテル (CVC)
    • 末梢穿刺中心静脈カテーテル (PICC)
    • 末梢静脈カテーテル (PIVC)
    • 透析カテーテル
    • 超音波血管アクセスデバイス
    • カテーテル固定器具
    • シリンジ (注射器)・針
  • 製品パイプライン
    • Alliance Vascular Devices, LLC
    • AngioDynamics
    • Bluegrass Vascular Technologies, Inc.
    • C.R. Bard
    • M. C. Johnson
    • Nipro Medical
    • Parasol Medical
    • PAVmed Inc.
    • Phase One Medical
    • Prodigy Diabetes Care, LLC.
    • Sharklet Technologies, Inc.
    • Starboard Medical
    • Teleflex Medical
    • Vascular Access Technologies, Inc.

各国のプロファイル

  • イントロダクション
    • 人口
    • 1人当たりGDP
    • 価格指数
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • ベネルクス諸国
  • 北欧諸国
  • オーストリア
  • スイス
  • ポルトガル

略語一覧

付録II:企業のプレスリリース

図表一覧

目次
Product Code: iDATA_EUVA17_MF

Europe-wide legislation encouraging the use of safety devices implemented in 2013 and early 2014 have been transposed in all countries included in this report. In addition, regions in Europe have passed their own laws to promote the use of safety devices such as syringes and needles in the workplace. Safety products carry a significant price premium compared to conventional products; the higher ASPs of these safety devices have increased the value of the market, and ongoing conversion is expected to boost future growth. While the conversion to the use of safety needles and PIVCs is taking place in Europe following the introduction of the directive by the Council of the European Union, lack of enforcement by local authorities will hinder the conversion to safety devices. In 2016, it was estimated that approximately 90% of patients who were hospitalized in the Western European region received vascular access treatment during their stay. The ability to infuse medications or fluids into a patient's bloodstream is indispensable to modern medicine. Vascular access devices include peripheral intravenous catheters (PIVCs), peripherally inserted central catheters (PICCs), central venous catheters (CVCs), implantable ports, Huber needles, dialysis catheters, manufactured catheter securement devices and syringes and needles. The European market for vascular access devices and accessories includes Germany, France, Italy, the United Kingdom, Spain, Benelux (the Netherlands, Belgium and Luxembourg), Scandinavia (Sweden, Norway, Denmark and Finland), Portugal, Austria and Switzerland.

TABLE OF CONTENTS

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY

EUROPEAN MARKET FOR VASCULAR ACCESS DEVICES AND ACCESSORIES OVERVIEW

COMPETITIVE ANALYSIS

MARKET TRENDS

MARKET DEVELOPMENTS

PROCEDURE NUMBERS

MARKETS INCLUDED

KEY REPORT UPDATES

VERSION HISTORY

RESEARCH METHODOLOGY

  • 1.1. RESEARCH SCOPE
  • 1.2. IDATA'S 9-STEP METHODOLOGY
    • Step 1: Project Initiation & Team Selection
    • Step 2: Prepare Data Systems and Perform Secondary Research
    • Step 3: Preparation for Interviews & Questionnaire Design
    • Step 4: Performing Primary Research
    • Step 5: Research Analysis: Establishing Baseline Estimates
    • Step 6: Market Forecast and Analysis
    • Step 7: Identify Strategic Opportunities
    • Step 8: Final Review and Market Release
    • Step 9: Customer Feedback and Market Monitoring

DISEASE OVERVIEW

  • 2.1. BASIC ANATOMY
    • 2.1.1. Human Vascular System
  • 2.2. VASCULAR PATHOLOGY AND DISORDERS
    • 2.2.1. Cancer
    • 2.2.2. End-Stage Renal Disease
    • 2.2.3. Diabetes

PRODUCT ASSESSMENT

  • 3.1. PRODUCT PORTFOLIOS
    • 3.1.1. Implantable Port Devices
      • 3.1.1.1. Introduction
      • 3.1.1.1.1. Implantable Port Patients
      • 3.1.1.1.2. Port Implantation Procedures
      • 3.1.1.1.3. Port Infusion
      • 3.1.1.1.4. Port Maintenance
      • 3.1.1.2. AngioDynamics
      • 3.1.1.2.1. BioFlo®
      • 3.1.1.2.2. LifePort®
      • 3.1.1.2.3. Smart Port® CT
      • 3.1.1.2.4. TitanPort®
      • 3.1.1.2.5. Triumph-1®
      • 3.1.1.2.6. Vortex®
      • 3.1.1.2.7. Xcela™ Plus
      • 3.1.1.3. B. Braun
      • 3.1.1.3.1. Celsite®
      • 3.1.1.4. Cook Medical
      • 3.1.1.4.1. Vital-Port®
      • 3.1.1.5. C.R. Bard
      • 3.1.1.5.1. PowerPort®
      • 3.1.1.5.2. SlimPort®
      • 3.1.1.5.3. X-Port™
      • 3.1.1.5.4. Other Port Offerings
      • 3.1.1.6. Medcomp
      • 3.1.1.6.1. Dignity®
      • 3.1.1.6.2. Pro-Fuse® CT
      • 3.1.1.7. PFM Medical
      • 3.1.1.7.1. T-Port™
      • 3.1.1.7.2. TitaJet™
      • 3.1.1.7.3. Jet Port®
      • 3.1.1.7.4. DualPort
      • 3.1.1.8. Smiths Medical
      • 3.1.1.8.1. P.A.S. PORT®
      • 3.1.1.8.2. PORT-A-CATH®
      • 3.1.1.9. Teleflex Medical
      • 3.1.1.9.1. Polysite®
    • 3.1.2. Port Needles
      • 3.1.2.1. Introduction
      • 3.1.2.2. AngioDynamics
      • 3.1.2.2.1. LifeGuard®
      • 3.1.2.2.2. LifePort®
      • 3.1.2.3. B. Braun
      • 3.1.2.3.1. WHIN®
      • 3.1.2.4. Cook Medical
      • 3.1.2.4.1. Vital-Ject™
      • 3.1.2.5. C. R. Bard
      • 3.1.2.5.1. PowerLoc®
      • 3.1.2.5.2. Other Port Needle Offerings
      • 3.1.2.6. Kawasumi
      • 3.1.2.6.1. K-Shield®
      • 3.1.2.6.2. Other Port Needle Offerings
      • 3.1.2.7. MPS Medical, Inc.
      • 3.1.2.7.1. SmartSafety®
      • 3.1.2.8. Nipro Medical
      • 3.1.2.8.1. SafeTouch™
      • 3.1.2.9. Smiths Medical
      • 3.1.2.9.1. GRIPPER®
      • 3.1.2.9.2. GRIPPER PLUS®
      • 3.1.2.9.3. Other Port Needle Offerings
      • 3.1.2.10. Vygon (Churchill Medical Systems)
      • 3.1.2.10.1. LifeGuard™
      • 3.1.2.10.2. Wing Safe™
    • 3.1.3. Central Venous Catheters
      • 3.1.3.1. Introduction
      • 3.1.3.1.1. CVC Procedures
      • 3.1.3.1.2. CVC Kits
      • 3.1.3.1.3. CVC Market Segments
      • 3.1.3.2. AngioDynamics
      • 3.1.3.2.1. NeoStar™
      • 3.1.3.3. Centurion Medical Products
      • 3.1.3.3.1. Vantex™
      • 3.1.3.3.2. Multi-Med™
      • 3.1.3.3.3. AVA™
      • 3.1.3.4. Cook Medical
      • 3.1.3.4.1. Spectrum®
      • 3.1.3.5. C.R. Bard
      • 3.1.3.5.1. PowerHohn®
      • 3.1.3.5.2. Hohn®
      • 3.1.3.5.3. Other CVC Offerings
      • 3.1.3.6. Medcomp Inc.
      • 3.1.3.6.1. Pro-Line®
      • 3.1.3.6.2. Vascu-Line®
      • 3.1.3.6.3. Other CVC Offerings
      • 3.1.3.7. Teleflex Medical
      • 3.1.3.7.1. Standard
      • 3.1.3.7.2. ARROWg+ard Blue®
      • 3.1.3.7.3. ARROWg+ard Blue Plus®
      • 3.1.3.7.4. Chlorag+ard®
    • 3.1.4. Peripherally Inserted Central Catheters
      • 3.1.4.1. Introduction
      • 3.1.4.1.1. PICC Placement
      • 3.1.4.2. AngioDynamics
      • 3.1.4.2.1. BioFlo®
      • 3.1.4.3. Argon Medical
      • 3.1.4.3.1. First PICC™
      • 3.1.4.3.2. L-Cath™
      • 3.1.4.4. B. Braun
      • 3.1.4.4.1. V-5™
      • 3.1.4.4.2. Other PICC Offerings
      • 3.1.4.5. Cook Medical
      • 3.1.4.5.1. Spectrum®
      • 3.1.4.5.2. Other PICC Offerings
      • 3.1.4.6. C.R. Bard
      • 3.1.4.6.1. PowerPICC®
      • 3.1.4.6.2. Groshong®
      • 3.1.4.6.3. Per-Q-Cath®
      • 3.1.4.6.4. Other PICC Offerings
      • 3.1.4.7. GaltNeedleTech
      • 3.1.4.7.1. SYNERGY™
      • 3.1.4.8. Medcomp
      • 3.1.4.8.1. Pro-PICC™
      • 3.1.4.8.2. Vascu-PICC™
      • 3.1.4.9. Neo Medical
      • 3.1.4.9.1. Neo-Magic™
      • 3.1.4.9.2. V-Cath™
      • 3.1.4.10. PFM Medical
      • 3.1.4.10.1. pfm CT PICC II
      • 3.1.4.11. Teleflex Medical
      • 3.1.4.11.1. ARROW®
      • 3.1.4.12. Trinity Sterile
      • 3.1.4.12.1. Trinity™ PICC II
      • 3.1.4.13. Vygon
      • 3.1.4.13.1. Premicath™
      • 3.1.4.13.2. Epicutaneo-Cava™
      • 3.1.4.13.3. Nutriline™
      • 3.1.4.13.4. Lifecath™
    • 3.1.5. Peripheral Intravenous Catheters
      • 3.1.5.1. Introduction
      • 3.1.5.2. Access Scientific
      • 3.1.5.2.1. POWERWAND®
      • 3.1.5.3. AngioDynamics
      • 3.1.5.3.1. BioFlo®
      • 3.1.5.4. Argon Medical
      • 3.1.5.4.1. First Midcath™
      • 3.1.5.4.2. L-Cath™
      • 3.1.5.5. B. Braun
      • 3.1.5.5.1. Introcan Safety®
      • 3.1.5.6. Becton Dickinson
      • 3.1.5.6.1. Nexiva™
      • 3.1.5.6.2. Saf-T-Intima™
      • 3.1.5.6.3. Autoguard™
      • 3.1.5.7. C.R. Bard
      • 3.1.5.7.1. AccuCath®
      • 3.1.5.7.2. PowerGlide®
      • 3.1.5.7.3. Bard® Poly
      • 3.1.5.7.4. Other Midline Offerings
      • 3.1.5.8. GaltNeedleTech
      • 3.1.5.8.1. Nexus™
      • 3.1.5.9. Medcomp
      • 3.1.5.9.1. Medcomp® Midline
      • 3.1.5.10. MediKit
      • 3.1.5.10.1. Supercath™
      • 3.1.5.11. Neo Medical
      • 3.1.5.11.1. PowerStick™
      • 3.1.5.11.2. Neo-Magic®
      • 3.1.5.12. Nipro Medical
      • 3.1.5.12.1. Nipro™ IV Catheter
      • 3.1.5.13. Retractable Technologies, Inc.
      • 3.1.5.13.1. VanishPoint®
      • 3.1.5.14. Smiths Medical
      • 3.1.5.14.1. ViaValve™
      • 3.1.5.14.2. PROTECTIV®
      • 3.1.5.14.3. ACUVANCE®
      • 3.1.5.14.4. Other PIVC offerings
      • 3.1.5.15. Tangent Medical
      • 3.1.5.15.1. NovaCath™
      • 3.1.5.16. Teleflex Medical
      • 3.1.5.16.1. ARROW®
      • 3.1.5.16.2. TwinCath®
      • 3.1.5.17. Terumo
      • 3.1.5.17.1. SurFlash®
      • 3.1.5.17.2. SURFLO®
      • 3.1.5.18. Vygon
      • 3.1.5.18.1. Leader-Flex™
    • 3.1.6. Dialysis Catheters
      • 3.1.6.1. Introduction
      • 3.1.6.1.1. AV Fistulae
      • 3.1.6.1.2. AV Grafts
      • 3.1.6.1.3. Dialysis Catheters
      • 3.1.6.2. AngioDynamics
      • 3.1.6.2.1. DuraMax®
      • 3.1.6.2.2. DuraFlow™
      • 3.1.6.2.3. Schon™
      • 3.1.6.2.4. Other Dialysis Catheter Offerings
      • 3.1.6.3. Argon Medical
      • 3.1.6.3.1. UltraStream™
      • 3.1.6.4. Baxter
      • 3.1.6.4.1. GamCath™
      • 3.1.6.5. Cook Medical
      • 3.1.6.5.1. Turbo-Flo®
      • 3.1.6.5.2. Tenckhoff™
      • 3.1.6.6. C.R. Bard
      • 3.1.6.6.1. EQUISTREAM®
      • 3.1.6.6.2. HemoSplit®
      • 3.1.6.6.3. HemoStar®
      • 3.1.6.6.4. Niagara™
      • 3.1.6.6.5. Other Dialysis Catheter Offerings
      • 3.1.6.7. Marvao Medical
      • 3.1.6.7.1. NexSite™
      • 3.1.6.8. Medcomp
      • 3.1.6.8.1. Split Cath®
      • 3.1.6.8.2. Hemo-Cath®
      • 3.1.6.8.3. Hemo-Flow®
      • 3.1.6.8.4. Other Dialysis Catheter Offerings
      • 3.1.6.9. Medtronic
      • 3.1.6.9.1. MAHURKAR™
      • 3.1.6.9.2. Palindrome™
      • 3.1.6.9.3. Other Dialysis Catheter Offerings
      • 3.1.6.10. Merit Medical
      • 3.1.6.10.1. Flex-Neck®
      • 3.1.6.10.2. Centros™
      • 3.1.6.10.3. ProGuide™
      • 3.1.6.11. PFM Medical
      • 3.1.6.11.1. Veta™
      • 3.1.6.12. Phase One Medical
      • 3.1.6.12.1. Symetrex™
      • 3.1.6.13. Teleflex Medical
      • 3.1.6.13.1. NextStep®
      • 3.1.6.13.2. VectorFlow™
      • 3.1.6.13.3. Other Dialysis Catheter Offerings
    • 3.1.7. Ultrasound Vascular Access Devices
      • 3.1.7.1. Introduction
      • 3.1.7.1.1. Alternates to Ultrasound Guidance
      • 3.1.7.1.2. Ultrasound Guidance
      • 3.1.7.1.3. Ultrasound Vessel Mapping
      • 3.1.7.1.4. Tip Location
      • 3.1.7.1.5. General Ultrasound Imaging Systems with Vascular Access Guidance Capabilities Market
      • 3.1.7.2. Analogic
      • 3.1.7.2.1. Sonic Window™
      • 3.1.7.3. AngioDynamics
      • 3.1.7.3.1. Celerity™
      • 3.1.7.4. Chison
      • 3.1.7.4.1. EC0™
      • 3.1.7.4.2. Other Ultrasound Offerings
      • 3.1.7.5. C.R. Bard
      • 3.1.7.5.1. Site~Rite®
      • 3.1.7.5.2. Sherlock®
      • 3.1.7.6. Esaote North America
      • 3.1.7.6.1. MyLab™
      • 3.1.7.7. eZono
      • 3.1.7.7.1. eZono®
      • 3.1.7.8. FUJIFILM SonoSite, Inc.
      • 3.1.7.8.1. S Series™
      • 3.1.7.8.2. NanoMaxx®
      • 3.1.7.8.3. Edge® II
      • 3.1.7.8.4. M-Turbo®
      • 3.1.7.8.5. iViz®
      • 3.1.7.9. GE Healthcare
      • 3.1.7.9.1. Vscan™
      • 3.1.7.9.2. LOGIQ™
      • 3.1.7.9.3. Venue™
      • 3.1.7.10. Konica Minolta
      • 3.1.7.10.1. Sonimage™ P3
      • 3.1.7.11. Medcomp
      • 3.1.7.11.1. Navigator® BioNavigation™
      • 3.1.7.12. Mobisante
      • 3.1.7.12.1. MobiUS™
      • 3.1.7.13. Philips
      • 3.1.7.13.1. Lumify™
      • 3.1.7.14. Romedex
      • 3.1.7.14.1. Nautilus™
      • 3.1.7.15. Siemens
      • 3.1.7.15.1. ACUSON™
      • 3.1.7.16. SIUI
      • 3.1.7.16.1. Apogee™
      • 3.1.7.16.2. CTS™
      • 3.1.7.17. SonoScape
      • 3.1.7.17.1. S™
      • 3.1.7.17.2. A™
      • 3.1.7.18. Teleflex Medical
      • 3.1.7.18.1. ARROW® VPS®
      • 3.1.7.19. Terason
      • 3.1.7.19.1. uSmart®
      • 3.1.7.20. Toshiba
      • 3.1.7.20.1. Viamo™
      • 3.1.7.21. Zonare
      • 3.1.7.21.1. M™
      • 3.1.7.21.2. Other Ultrasound Offerings
    • 3.1.8. Catheter Securement Devices
      • 3.1.8.1. Introduction
      • 3.1.8.1.1. Catheter Stabilization Methods
      • 3.1.8.2. 3M
      • 3.1.8.2.1. 3M™ PICC/CVC Securement Systems
      • 3.1.8.2.2. Tegaderm™
      • 3.1.8.2.3. 3M™ Medical Tapes
      • 3.1.8.3. Baxter
      • 3.1.8.3.1. VITAL-HOLD™
      • 3.1.8.4. Cardinal Health
      • 3.1.8.4.1. Original Boarder
      • 3.1.8.4.2. Advanced IV
      • 3.1.8.5. Centurion Medical
      • 3.1.8.5.1. SorbaView®
      • 3.1.8.5.2. Other Product Offerings
      • 3.1.8.6. C.R. Bard
      • 3.1.8.6.1. StatLock® IV
      • 3.1.8.6.2. StatLock® PICC
      • 3.1.8.6.3. StatLock® CV
      • 3.1.8.6.4. StatLock® Dialysis
      • 3.1.8.6.5. Other StatLock® Offerings
      • 3.1.8.7. Insightra Medical
      • 3.1.8.7.1. Modulare®
      • 3.1.8.8. Interrad Medical
      • 3.1.8.8.1. SecurAcath®
      • 3.1.8.9. Johnson & Johnson
      • 3.1.8.9.1. BioPatch®
      • 3.1.8.9.2. Other Product Offerings
      • 3.1.8.10. M.C. Johnson
      • 3.1.8.10.1. CATH-SECURE™
      • 3.1.8.11. Medtronic
      • 3.1.8.11.1. Kendall™
      • 3.1.8.11.2. Other Product Offerings
      • 3.1.8.12. Neo Medical
      • 3.1.8.12.1. V-Lock™
      • 3.1.8.13. Smith & Nephew
      • 3.1.8.13.1. IV3000®
      • 3.1.8.13.2. HYPAFIX®
      • 3.1.8.13.3. PRIMAPORE®
      • 3.1.8.14. Starboard Medical
      • 3.1.8.14.1. CLIK-IT™
      • 3.1.8.15. TIDI Products
      • 3.1.8.15.1. Grip-Lok® PICC Securement
      • 3.1.8.15.2. Grip-Lok® CVC Securement
      • 3.1.8.15.3. Grip-Lok® PIVC Securement
    • 3.1.9. Syringe and Needles
      • 3.1.9.1. Introduction
      • 3.1.9.2. Allison Medical
      • 3.1.9.2.1. SureComfort™
      • 3.1.9.3. B. Braun
      • 3.1.9.3.1. Injekt®
      • 3.1.9.3.2. Other Syringe & Needle Offerings
      • 3.1.9.4. Becton Dickinson
      • 3.1.9.4.1. BD™ Insulin Syringes
      • 3.1.9.4.2. BD™ Allergy Syringes
      • 3.1.9.4.3. BD™ Tuberculin Syringes
      • 3.1.9.4.4. BD™ Syringes & Needles
      • 3.1.9.4.5. BD PrecisionGlide™ Needles
      • 3.1.9.4.6. BD Safety-Lok™ Syringes
      • 3.1.9.4.7. BD SafetyGlide™ Syringes & Needles
      • 3.1.9.4.8. BD Eclipse™ Needles and Syringes
      • 3.1.9.4.9. BD Integra™ Needles and Syringes
      • 3.1.9.4.10. BD AutoShield™
      • 3.1.9.4.11. Ultra-Fine™
      • 3.1.9.5. Cardinal Health
      • 3.1.9.5.1. Cardinal Health™
      • 3.1.9.6. Delta Hi-Tech, Inc.
      • 3.1.9.6.1. AIMSCO®
      • 3.1.9.7. Medical Plastic Devices, Inc.
      • 3.1.9.7.1. Insupen®
      • 3.1.9.8. Medtronic
      • 3.1.9.8.1. Magellan™
      • 3.1.9.8.2. Monoject™
      • 3.1.9.9. MYCO Medical
      • 3.1.9.9.1. Dispovan®
      • 3.1.9.10. Nipro Medical
      • 3.1.9.10.1. Nipro™
      • 3.1.9.11. Novo Nordisk
      • 3.1.9.11.1. NovoFine®
      • 3.1.9.11.2. NovoTwist®
      • 3.1.9.12. Owen Mumford, Inc.
      • 3.1.9.12.1. Unifine®
      • 3.1.9.13. Perrigo
      • 3.1.9.13.1. Clickfine®
      • 3.1.9.14. Protectus Medical Devices
      • 3.1.9.14.1. Protectus®
      • 3.1.9.15. ReliOn
      • 3.1.9.15.1. ReliOn®
      • 3.1.9.16. Retractable Technologies, Inc.
      • 3.1.9.16.1. VanishPoint®
      • 3.1.9.16.2. Patient Safe®
      • 3.1.9.17. Revolutions Medical
      • 3.1.9.17.1. ReVac™
      • 3.1.9.18. Safety 1st Medical
      • 3.1.9.18.1. Safe-1®
      • 3.1.9.19. Smiths Medical
      • 3.1.9.19.1. Needle-Pro®
      • 3.1.9.20. SOL-MILLENNIUM
      • 3.1.9.20.1. SOL-CARE®
      • 3.1.9.20.2. SOL-M™
      • 3.1.9.20.3. SOL-GUARD™
      • 3.1.9.21. STAT Medical Devices
      • 3.1.9.21.1. Super-Fine™
      • 3.1.9.22. Terumo
      • 3.1.9.22.1. SurGuard®
      • 3.1.9.22.2. TERUMO®
      • 3.1.9.23. UltiCare
      • 3.1.9.23.1. UltiCare®
  • 3.2. REGULATORY ISSUES AND RECALLS
    • 3.2.1. November 2015
    • 3.2.2. October 2015
    • 3.2.3. September 2015
    • 3.2.4. August 2015
    • 3.2.5. July 2015
    • 3.2.6. April 2015
    • 3.2.7. March 2015
    • 3.2.8. February 2015
    • 3.2.9. January 2015
    • 3.2.10. December 2014
    • 3.2.11. October 2014
    • 3.2.12. September 2014
    • 3.2.13. May 2014
    • 3.2.14. April 2014
    • 3.2.15. March 2014
    • 3.2.16. January 2014
    • 3.2.17. December 2013
    • 3.2.18. September 2013
    • 3.2.19. August 2013
    • 3.2.20. June 2013
    • 3.2.21. March 2013
    • 3.2.22. February 2013
    • 3.2.23. December 2012
    • 3.2.24. August 2012
    • 3.2.25. June 2012
    • 3.2.26. May 2012
    • 3.2.27. March 2012
    • 3.2.28. February 2012
    • 3.2.29. January 2012
  • 3.3. CLINICAL TRIALS
    • 3.3.1. Implantable Port Devices
    • 3.3.2. Central Venous Catheters
    • 3.3.3. Peripherally Inserted Central Catheters
    • 3.3.4. Peripheral Intravenous Catheters
    • 3.3.5. Dialysis Catheters
    • 3.3.6. Ultrasound Vascular Access Devices
    • 3.3.7. Catheter Securement Devices
    • 3.3.8. Syringe and Needles
  • 3.4. PRODUCT PIPELINES
    • 3.4.1. Alliance Vascular Devices, LLC
      • 3.4.1.1. FreeHand Safety Huber Needle®
    • 3.4.2. AngioDynamics
      • 3.4.2.1. Celerity™ PICC Tip Confirmation System with Navigation
      • 3.4.2.2. Firefly
      • 3.4.2.3. BioFlo® PICC Line Extension
      • 3.4.2.4. BioFlo® Port Line Extension
      • 3.4.2.5. Next Generation BioFlo® PICC
      • 3.4.2.6. Next Generation BioFlo® Port
    • 3.4.3. Bluegrass Vascular Technologies, Inc.
      • 3.4.3.1. Surfacer® Inside-Out™ Access System
    • 3.4.4. C.R. Bard
      • 3.4.4.1. Chemical-Resistant PICCs
      • 3.4.4.2. Novel Advanced Material PICCs
      • 3.4.4.3. PowerGlide® Pro Midline
      • 3.4.4.4. AccuCath®
      • 3.4.4.5. Xenesis™ Acute Hemodialysis Catheter
      • 3.4.4.6. Site~Rite® 8 Ultrasound System
    • 3.4.5. M. C. Johnson
      • 3.4.5.1. PICC Securement Device
    • 3.4.6. Nipro Medical
      • 3.4.6.1. Shielding Safety Needle
      • 3.4.6.2. Safety Syringe
      • 3.4.6.3. Safety PIVC
    • 3.4.7. Parasol Medical
      • 3.4.7.1. Catheter Securement Device
    • 3.4.8. PAVmed Inc.
      • 3.4.8.1. NextCath™
    • 3.4.9. Phase One Medical
      • 3.4.9.1. Goldilocks™ Long Term Hemodialysis Catheter
      • 3.4.9.2. Triple-Lumen Symetrex™ Hemodialysis Catheter
    • 3.4.10. Prodigy Diabetes Care, LLC.
      • 3.4.10.1. Insulin Pen Needles
    • 3.4.11. Sharklet Technologies, Inc.
      • 3.4.11.1. Sharklet™ Central Venous Catheter
    • 3.4.12. Starboard Medical
      • 3.4.12.1. Catheter Securement Devices
    • 3.4.13. Teleflex Medical
      • 3.4.13.1. Arrow® Endurance™ Extended Dwell Peripheral Catheter System
      • 3.4.13.2. Tip Confirmation for CVCs, Chronic Hemodialysis Catheters & Ports
    • 3.4.14. Vascular Access Technologies, Inc.
      • 3.4.14.1. SAFECVAD™

COUNTRY PROFILES

  • 4.1. INTRODUCTION
    • 4.1.1. Population
    • 4.1.2. GDP Per Capita
    • 4.1.3. Price Index
  • 4.2. GERMANY
  • 4.3. FRANCE
  • 4.4. UNITED KINGDOM
  • 4.5. ITALY
  • 4.6. SPAIN
  • 4.7. BENELUX
  • 4.8. SCANDINAVIA
  • 4.9. AUSTRIA
  • 4.10. SWITZERLAND
  • 4.11. PORTUGAL

ABBREVIATIONS

APPENDIX II: COMPANY PRESS RELEASES

LIST OF CHARTS

  • Chart 1-1: Vascular Access Device and Accessories Market by Segment, Europe, 2013-2023
  • Chart 1-2: Vascular Access Device and Accessories Market Overview, Europe, 2016 & 2023
  • Chart 3-1: Central Venous Catheter Market Segments, 2015
  • Chart 4-1: Country Profile, Germany, 2016
  • Chart 4-2: Country Profile, France, 2016
  • Chart 4-3: Country Profile, United Kingdom, 2016
  • Chart 4-4: Country Profile, Italy, 2016
  • Chart 4-5: Country Profile, Spain, 2016
  • Chart 4-6: Country Profile, Benelux, 2016
  • Chart 4-7: Country Profile, Scandinavia, 2016
  • Chart 4-8: Country Profile, Austria, 2016
  • Chart 4-9: Country Profile, Switzerland, 2016
  • Chart 4-10: Country Profile, Portugal, 2016

LIST OF FIGURES

  • Figure 1-1: Vascular Access Device and Accessories Competitor Market Share Ranking by Segment, Europe, 2016(1 of 2)
  • Figure 1-2: Vascular Access Device and Accessories Competitor Market Share Ranking by Segment, Europe, 2016(2 of 2)
  • Figure 1-3: Companies Researched in this Report, Europe, 2016
  • Figure 1-4: Factors Impacting the Vascular Access Device and Accessories Market by Segment, Europe, 2016
  • Figure 1-5: Recent Events in the Vascular Access Device and Accessories Market, Europe, 2013-2016
  • Figure 1-6: Vascular Access Procedures Covered, Europe, 2016
  • Figure 1-7: Vascular Access Device and Accessories Markets Covered, Europe, 2016(1 of 3)
  • Figure 1-8: Vascular Access Device and Accessories Markets Covered, Europe, 2016(2 of 3)
  • Figure 1-9: Vascular Access Device and Accessories Markets Covered, Europe, 2016(3 of 3)
  • Figure 1-10: Key Report Updates
  • Figure 1-11: Version History
  • Figure 3-1: Class 2 Device Recall Medtronic
  • Figure 3-2: Class 2 Device Recall Smiths Medical
  • Figure 3-3: Class 2 Device Recall Arrow
  • Figure 3-4: Class 2 Device Recall Arrow
  • Figure 3-5: Class 2 Device Recall Covidien(Medtronic)
  • Figure 3-6: Class 2 Device Recall Arrow
  • Figure 3-7: Class 2 Device Recall Medline
  • Figure 3-8: Class 2 Device Recall Arrow
  • Figure 3-9: Class 2 Device Recall B. Braun
  • Figure 3-10: Class 3 Device Recall Bard Access
  • Figure 3-11: Class 2 Device Recall Covidien(Medtronic)
  • Figure 3-12: Class 2 Device Recall Bard Access
  • Figure 3-13: Class 2 Device Recall Bard Access
  • Figure 3-14: Class 2 Device Recall Medcomp & AngioDynamics
  • Figure 3-15: Class 2 Device Recall Bard Access
  • Figure 3-16: Class 2 Device Recall Arrow
  • Figure 3-17: Class 2 Device Recall Medcomp
  • Figure 3-18: Class 2 Device Recall Arrow
  • Figure 3-19: Class 2 Device Recall Arrow
  • Figure 3-20: Class 2 Device Recall Smiths Medical
  • Figure 3-21: Class 2 Device Recall PFM Medical
  • Figure 3-22: Class 2 Device Recall PFM Medical
  • Figure 3-23: Class 2 Device Recall Becton Dickinson
  • Figure 3-24: Class 2 Device Recall Arrow
  • Figure 3-25: Class 2 Device Recall Arrow
  • Figure 3-26: Class 2 Device Recall Navilyst Medical
  • Figure 3-27: Class 2 Device Recall Argon Medical
  • Figure 3-28: Class 2 Device Recall Arrow
  • Figure 3-29: Class 2 Device Recall Arrow
  • Figure 3-30: Class 2 Device Recall Arrow
  • Figure 3-31: Class 2 Device Recall Bard Access
  • Figure 3-32: Class 2 Device Recall Navilyst Medical
  • Figure 3-33: Class 2 Device Recall Bard Access
  • Figure 3-34: Class 2 Device Recall Smiths Medical
  • Figure 3-35: Class 2 Device Recall B. Braun
  • Figure 3-36: Class 2 Device Recall Smiths Medical
  • Figure 3-37: Class 2 Device Recall Access Scientific
  • Figure 3-38: Class 2 Device Recall Covidien(Medtronic)
  • Figure 3-39: Class 2 Device Recall Arrow
  • Figure 3-40: Class 2 Device Recall Bard Access
  • Figure 3-41: Class 2 Device Recall Becton Dickinson
  • Figure 3-42: Class 2 Device Recall Churchill Medical Systems, Inc. A Vygon Company
  • Figure 3-43: Class 2 Device Recall Bard Access
  • Figure 3-44: Class 2 Device Recall Churchill Medical Systems, Inc. A Vygon Company
  • Figure 3-45: Class 2 Device Recall Medcomp
  • Figure 3-46: Class 2 Device Recall Becton Dickinson
  • Figure 3-47: Class 3 Device Recall Bard Access
  • Figure 3-48: Class 2 Device Recall Medcomp
  • Figure 3-49: Class 1 Device Recall Arrow
  • Figure 3-50: Class 2 Device Recall Arrow
  • Figure 3-51: Class 2 Device Recall Vygon
  • Figure 3-52: Class 2 Device Recall Covidien(Medtronic)
  • Figure 3-53: Class 2 Device Recall Medcomp
  • Figure 3-54: Class 2 Device Recall Churchill Medical Systems, Inc. A Vygon Company
  • Figure 3-55: Class 2 Device Recall Christie Medical Holdings
  • Figure 3-56: Class 3 Recall Bard Access
  • Figure 3-57: Class 2 Device Recall AngioDynamics
  • Figure 3-58: Class 2 Device Recall Becton Dickinson
  • Figure 3-59: Class 2 Device Recall AngioDynamics
  • Figure 3-60: Class 2 Device Recall AngioDynamics
  • Figure 3-61: Class 3 Device Recall AngioDynamics
  • Figure 3-62: Class 2 Device Recall AngioDynamics
  • Figure 3-63: Bone Anchored Port-a Novel Vascular Access for Hemodialysis Treatment
  • Figure 3-64: A Pragmatic Randomized Trial
  • Figure 3-65: Assessment of a Power Injectable vs. a Non-Power Injectable
  • Figure 3-66: Vascular Access in Cancer Patients
  • Figure 3-67: Ultrasound-guided Subclavian Vein Puncture Versus Cephalic Vein Dissection
  • Figure 3-68: Central Line Placement Study
  • Figure 3-69: The Effects of Anti-infective Central Venous Catheter(CVC)
  • Figure 3-70: The Use of Point of Care Ultra Sound
  • Figure 3-71: Complications Associated With Central Venous Access
  • Figure 3-72: Impact of Ultrasound Guided Central Venous Catheterization
  • Figure 3-73: Randomized, Prospective, Single-center Study
  • Figure 3-74: Remifentanil and Local Anesthesia
  • Figure 3-75: Dissemination of a Simulation-based Mastery Learning Curriculum
  • Figure 3-76: Incidence of Complication
  • Figure 3-77: Comparison of Two Needle Insertion Techniques
  • Figure 3-78: A Monocenter Prospective Study
  • Figure 3-79: A Prospective Study to Compare Point of Care Echocardiography Versus Chest Radiography
  • Figure 3-80: Long-versus Short-Axis Ultrasound Guidance for Subclavian Vein Cannulation
  • Figure 3-81: Use of Chlorhexidine-gel-Impregnated Dressing Compared to Transparent Polyurethane Film Dressing
  • Figure 3-82: Vascular Access in Hematological Patients
  • Figure 3-83: Developing and Maintaining a Central Venous Catheter Registry
  • Figure 3-84: Reliability of Central Venous Pressure Measurements
  • Figure 3-85: SUBclavian Central Venous Catheters Guidance and Examination by UltraSound
  • Figure 3-86: Chlorhexidine Containing IV-securement Dressings
  • Figure 3-87: Comparison of Effectiveness and Safety of Two Methods for Installing Femoral Central Venous Catheters
  • Figure 3-88: A Phase III Study of Peripherally Inserted Versus Centrally Inserted Central Venous Catheters
  • Figure 3-89: Ultrasound Guided Diagnosis of Central Venous Catheters in Children
  • Figure 3-90: Real-time Ultrasound-guided Catheterization of the Axillary Vein in the Intensive Care Unit
  • Figure 3-91: Determination of Anatomic Variations of the Internal Jugular and Femoral Veins
  • Figure 3-92: Comparison of Subclavian, Femoral and Internal Jugular Venous Catheterization
  • Figure 3-93: Landmark vs. Ultrasound Guided Subclavian Central Venous Catheter Placement
  • Figure 3-94: Interest of Ultrasound Coupled to a Guidance System(GPS)
  • Figure 3-95: Risk of Central Venous Stenosis in Patients With Chronic Renal Failure After IJ Line Placement
  • Figure 3-96: Comparison of the Central Venous Catheter Insertion Techniques
  • Figure 3-97: A Multicenter, Open-label, Randomised, Clinical Trial
  • Figure 3-98: A Pragmatic Randomized Trial Standard of Care Vascular Access Strategies
  • Figure 3-99: PICC and Midline Related Complications: A Multicenter Observational Study
  • Figure 3-100: Complications Associated With Central Venous Access
  • Figure 3-101: Evaluation of Electrocardiographic Guidance
  • Figure 3-102: Phase II Randomised Study Comparing the Tolerance of PICC Line
  • Figure 3-103: Randomized, Prospective, Single-center Study
  • Figure 3-104: A Randomized Controlled Trial Comparing Ultrasound Guided PICC Line Insertion
  • Figure 3-105: Ultrasound-guided Peripheral Vascular Access
  • Figure 3-106: Vascular Access in Cancer Patients
  • Figure 3-107: A Monocenter Prospective Study
  • Figure 3-108: Vascular Access in Hematological Patients
  • Figure 3-109: ECG Versus Ultrasound-guided Positioning of the Peripherally Inserted Central Catheter(PICC) Tip
  • Figure 3-110: Sequential Pneumatic Compression
  • Figure 3-111: Reliability of Central Venous Pressure Measurements
  • Figure 3-112: Time and Motion Related to PICC Insertion Process and Catheter Tip Confirmation
  • Figure 3-113: A Randomized Open-labeled Multicenter Study
  • Figure 3-114: A Phase III Study of Peripherally Inserted Versus Centrally Inserted Central Venous Catheters
  • Figure 3-115: A Randomized Prospective Multicenter Evaluation
  • Figure 3-116: Randomized Double Blind Comparison
  • Figure 3-117: An Observational, Prospective, Single-center Study of Placement and Confirmation
  • Figure 3-118: PICC and Midline Related Complications
  • Figure 3-119: Contribution of Ultrasound for Peripheral Intravenous Catheter Placement by Intensive Care Nurses
  • Figure 3-120: A Comparison of Accuvein to Standard Intravenous Access
  • Figure 3-121: Randomized, Controlled Study of Ultrasound-Guided Peripheral Venous Access
  • Figure 3-122: Pen Torch Transillumination: Shedding Light on Difficult Venepuncture
  • Figure 3-123: Ultrasound-guided Peripheral Vascular Access in Children
  • Figure 3-124: Preventing Delay of Care in Patient With Difficult IV Access
  • Figure 3-125: A Randomized Control Trial of Ultrasound Guided IV Access
  • Figure 3-126: Removal Peripheral Intravenous Catheters According to Clinical Signs
  • Figure 3-127: Clinical Investigation Acc. to MPG §23b
  • Figure 3-128: Evaluation of Accuvein® in Obese Patients
  • Figure 3-129: A Randomized, Open Label Study to Evaluate the Effectiveness of the MMT Initial Specimen Diversion Device
  • Figure 3-130: Technique for Successful Ultrasound-guided Peripheral Vascular Access
  • Figure 3-131: A Randomized Controlled Open Label Trial
  • Figure 3-132: A Prospective Feasibility Trial of AccuCath® 2.25" BC Intravascular Catheter System
  • Figure 3-133: The Use of a Topical Anesthetic Skin Refrigerant
  • Figure 3-134: A Randomized Controlled Trial to Demonstrate the Safety and Efficacy of the OptiVein® IV Catheter
  • Figure 3-135: Observational Study of the Sonic Window™ Handheld Ultrasound System
  • Figure 3-136: Near-Infrared Software Performance Study
  • Figure 3-137: A Randomized Controlled Trial To Compare The Initial Success Rate
  • Figure 3-138: A Clinical Assessment of an Ultrasound-guided Inserted Peripheral Intravenous Catheter
  • Figure 3-139: Ultrasound Guided Peripheral Intravenous Catheter Insertion
  • Figure 3-140: Nurse Peripheral Intravenous Catheter Insertion Success
  • Figure 3-141: ACCESS HD Pilot
  • Figure 3-142: Randomized Controlled Trial of Straight Versus Coiled Peritoneal Dialysis
  • Figure 3-143: Randomized Trial Comparing VectorFlow™ Tunneled Dialysis Catheter
  • Figure 3-144: Duration and Adverse Events of Non-cuffed Catheter
  • Figure 3-145: Vascular Access Choice and Outcomes in the Elderly and Very Elderly
  • Figure 3-146: Prevention of Tunneled Cuffed Catheter Malfunction
  • Figure 3-147: Analysis of CRBSI
  • Figure 3-148: A Prospective Multicenter Investigation
  • Figure 3-149: Comparison of an Intensive Versus a Standard Hemodialysis Central Venous Catheter
  • Figure 3-150: Post Marketing Surveillance of the CentrosFLO™ Tunneled IJ Catheter for Dialysis
  • Figure 3-151: Comparison of Self-locating Catheter Versus a Straight Catheter for Outflow Problems
  • Figure 3-152: Multi-Center, Prospective, Randomized, Open-Label, Sponsor-Blinded, Active-Control(Heparin) Clinical Investigation
  • Figure 3-153: Comparative Effectiveness of 30% Trisodium Citrate and Heparin Lock Solutions
  • Figure 3-154: The Use of Point of Care Ultra Sound for Correct Placement
  • Figure 3-155: Contribution of Ultrasound for Peripheral Intravenous Catheter
  • Figure 3-156: Evaluation of Electrocardiographic Guidance
  • Figure 3-157: Impact of Ultrasound Guided Central Venous Catheterization
  • Figure 3-158: A Comparison of Accuvein to Standard Intravenous Access
  • Figure 3-159: Randomized, Controlled Study of Ultrasound-Guided Peripheral Venous Access
  • Figure 3-160: Pen Torch Transillumination: Shedding Light on Difficult Venepuncture
  • Figure 3-161: Incidence of Complication Depending on the Cannulation Site
  • Figure 3-162: A Randomized Controlled Trial Comparing Ultrasound Guided PICC Line Insertion
  • Figure 3-163: Ultrasound-guided Peripheral Vascular Access in Children
  • Figure 3-164: Preventing Delay of Care in Patient With Difficult IV Access
  • Figure 3-165: Ultrasound-guided Peripheral Vascular Access
  • Figure 3-166: A Randomized Control Trial of Ultrasound Guided IV Access
  • Figure 3-167: Long-versus Short-Axis Ultrasound Guidance for Subclavian Vein Cannulation
  • Figure 3-168: A Prospective Study to Compare Point of Care Echocardiography Versus Chest Radiography
  • Figure 3-169: ECG Versus Ultrasound-guided Positioning
  • Figure 3-170: SUBclavian Central Venous Catheters Guidance and Examination
  • Figure 3-171: Evaluation of Accuvein® in Obese Patients
  • Figure 3-172: Time and Motion Related to PICC Insertion Process
  • Figure 3-173: Technique for Successful Ultrasound-guided Peripheral Vascular Access
  • Figure 3-174: A Randomized Open-labeled Multicenter Study
  • Figure 3-175: Comparison of Effectiveness and Safety of Two Methods for Installing Femoral Central Venous Catheters
  • Figure 3-176: Ultrasound Guided Diagnosis of Central Venous Catheters in Children
  • Figure 3-177: Real-time Ultrasound-guided Catheterization of the Axillary Vein
  • Figure 3-178: Observational Study of the Sonic Window™ Handheld Ultrasound System
  • Figure 3-179: Ultrasound-guided Subclavian Vein Puncture
  • Figure 3-180: Near-Infrared Software Performance Study
  • Figure 3-181: Landmark vs. Ultrasound Guided Subclavian Central Venous Catheter Placement
  • Figure 3-182: Interest of Ultrasound Coupled to a Guidance System(GPS)
  • Figure 3-183: A Randomized Controlled Trial
  • Figure 3-184: A Clinical Assessment of an Ultrasound-guided Inserted Peripheral Intravenous Catheter
  • Figure 3-185: Ultrasound Guided Peripheral Intravenous Catheter Insertion
  • Figure 3-186: An Observational, Prospective, Single-center Study
  • Figure 3-187: Nurse Peripheral Intravenous Catheter Insertion Success
  • Figure 3-188: Unit Based Comparison of Non-Versus Chlorhexidine-Impregnated Central Line Dressings
  • Figure 3-189: Use of Chlorhexidine-gel-Impregnated Dressing
  • Figure 3-190: Comparing SecurAcath® Versus StatLock®
  • Figure 3-191: Chlorhexidine Containing Iv-securement Dressings
  • Figure 3-192: A Randomized, Parallel Design Study
  • Figure 3-193: Pen Torch Transillumination: Shedding Light on Difficult Venepuncture
  • Figure 3-194: Transition From Parenteral Prostanoids to Inhaled Treprostinil
  • Figure 3-195: Efficacy, Safety and Acceptability of the New Pen Needle
  • Figure 3-196: A Phase I Study of the Safety, Reactogenicity, Acceptability and Immunogenicity
  • Figure 3-197: A Single Centre, Randomised, 3-period Cross-over Trial
  • Figure 3-198: A Phase IV, Non-Inferiority, Observer Blind, Randomized Clinical Study
  • Figure 3-199: Treating Diabetic Lipohypertrophy With Intensive Education
  • Figure 3-200: Pharmacokinetic Comparison of Intradermal Versus Sub-cutaneous Insulin
  • Figure 3-201: A Randomized, Multi-centre Cross-over Study
  • Figure 3-202: A Clinical Investigation to Evaluate the Safety and Performance
  • Figure 3-203: A Phase I, Randomized, Open-Label, Parallel-Group, Single-Dose, Multi-Center Study
  • Figure 3-204: Pharmacokinetic and Pharmacodynamic Profile of Insulin Lispro
  • Figure 3-205: Reproducibility of Insulin Action When Administered by Needle-free Jet Injection
  • Figure 3-206: Patient Experiences With Injection Needles
  • Figure 3-207: Inactivated Influenza Via Jet Injection
  • Figure 3-208: Intradermal Rabies Immunization Using NanoJect: A Comparative Study
  • Figure 3-209: Phase 1b, Partial-Blind, Parallel Group, Randomized Study
  • Figure 3-210: A Phase I, Open Label, CT to Evaluate the Safety, Tolerability and Immunogenicity
  • Figure 6-1: Press Release Summary
Back to Top